Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV ranitidine continuous infusion versus intermittent bolus administration on gastric pH in postoperative ICU patients
IRCT201409178384N4Phase 3Completed
- Sponsor
- Vice Chancellor for Research of Mashhad University of Medical Sciences
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ranitidine in stress ulcer (2 arms), sponsored by Vice Chancellor for Research of Mashhad University of Medical Sciences. Primary endpoint: Gastric pH. Started Aug 2013; status: completed.
02
Drugs
ranitidine
03
Conditions
stress ulcer
Beyond the preview
Go deeper on IRCT201409178384N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201409178384N4.